Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency.
Australian Institute of Health Innovation, University of New South Wales, Sydney, NSW, Australia. w.lipworth@unsw.edu.au
Wendy L
WL
Lipworth
Ken
K
Ho
Ian H
IH
Kerridge
Richard O
RO
Day
D000328:Adult; D001315:Australia; D003362:Cost-Benefit Analysis; D005380:Financing, Government; D006291:Health Policy; D020249:Hormone Replacement Therapy / Q000191:economics*; D019382:Human Growth Hormone / Q000172:deficiency / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy* / Q000191:economics; D009313:National Health Programs; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
D011994:Recombinant Proteins; D019382:Human Growth Hormone